Sarcopenia and Osteoporosis in Older People: a Systematic Review and Meta-analysis
Overview
Affiliations
Background: Age-related loss of muscle and bone (sarcopenia and osteoporosis), increases the risk of falls and fractures and consequently leads to a substantial economic burden for the society. The combined condition, osteosarcopenia, may identify patients at a higher risk of those outcomes and could be relevant for assessment and treatment in clinical practice.
Aim: To evaluate the current knowledge of the prevalence of osteosarcopenia and the fracture risk in older people.
Method: A systematic literature review was conducted until 10th March 2018. A total of 1105 papers were detected, whereof 1049 and 29 were excluded by title/abstracts and full-text assessment, respectively. Twenty-seven original papers were included in the systematic review, whereof 17 were suitable for meta-analysis.
Results: The prevalence of osteosarcopenia varied (5-37%) depending on the classification of sarcopenia and whether participants were classified initially according to sarcopenia or osteoporosis. In patients with low-energy osteoporotic fractures, sarcopenia was present in 7.8-58% and 1.3-96.3% of the cases, women and men, respectively. The meta-analysis of prevalence of sarcopenia in patients with low-energy fracture (n = 9) was 46% (95% CI 44, 48; p < 0.001). The relative risk of fracture (sarcopenic versus non-sarcopenic) in meta-analysis of four studies was 1.37 (95% CI 1.18, 1.59; p < 0.001). Mean bone mineral density (n = 5) and T-score (n = 3) of femoral neck was significantly lower in sarcopenic participants [- 0.07 g/cm (95% CI 0.08, 0.06) and - 0.34 (95% CI - 0.46, - 0.23), respectively].
Conclusion: Osteosarcopenia is frequent and the relative risk of fracture is higher among sarcopenic patients. A standard and strict classification of sarcopenia is needed to assess its true relationship and consequences.
Yekta E, Torkaman G, Aghaghazvini L Aging Clin Exp Res. 2024; 36(1):232.
PMID: 39625551 PMC: 11614992. DOI: 10.1007/s40520-024-02888-3.
Surov A, Ponisch W, Borggrefe J, Meyer H J Cancer Res Clin Oncol. 2024; 150(11):499.
PMID: 39546043 PMC: 11567988. DOI: 10.1007/s00432-024-06009-5.
Osteosarcopenia in patients with cancer: A systematic review and meta-analysis.
Wang C, Liu H, Lin W, Wu L, Guo H, Huang S Medicine (Baltimore). 2024; 103(45):e40476.
PMID: 39533564 PMC: 11557054. DOI: 10.1097/MD.0000000000040476.
Liu C, Chen G, Xia Y, Wang P, Zhao Z, Zhang J BMC Geriatr. 2024; 24(1):752.
PMID: 39261770 PMC: 11389292. DOI: 10.1186/s12877-024-05341-2.
Osteosarcopenia in Finland: prevalence and associated factors.
Blomqvist M, Nuotio M, Saaksjarvi K, Koskinen S, Stenholm S Arch Osteoporos. 2024; 19(1):80.
PMID: 39212839 PMC: 11364597. DOI: 10.1007/s11657-024-01439-7.